4 Min Read
WASHINGTON (Reuters) -A U.S. health advisory panel on Wednesday began a review of six reported cases of rare blood clots in women who received Johnson & Johnson’s COVID-19 vaccine, a day after federal regulators paused its use to assess the issue.
FILE PHOTO: Vials with a sticker reading, COVID-19 / Coronavirus vaccine / Injection only and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic
The cases, all in women under age 50, were reported out of 7.2 million doses of the J&J vaccine administered in the United States - a risk federal health officials and immunology experts said was extremely low, especially when weighed against the potential ravages of COVID-19.
U S advisory panel to review rare clot risk with J&J COVID-19 vaccine after its use was paused
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
U S Senator Perdue quarantining after coronavirus contact days before Georgia runoff vote
netscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from netscape.com Daily Mail and Mail on Sunday newspapers.
U.S. House panel subpoenas HHS, CDC leaders over COVID-19 response By Bart H. Meijer
Health and Human Services Secretary Alex Azar speaks before watching COVID-19 vaccines being administered to hospital workers at George Washington University Hospital in Washington
WASHINGTON (Reuters) -The head of a U.S. House Oversight Committee panel on COVID-19 on Monday issued subpoenas to two top Trump administration health officials over alleged political interference in the handling of the nation’s pandemic response.
U.S. Health Secretary Alex Azar and CDC Director Robert Redfield were ordered to produce related documents by Dec. 30, the head of the coronavirus subcommittee, U.S. Representative Jim Clyburn, said in a statement.
WASHINGTON (Reuters) The head of a U.S. House Oversight Committee panel on COVID-19 on Monday issued subpoenas to two top Trump administration health officials over accusations of political interference amid the nation s pandemic response.
U.S. Health Secretary Alex Azar and CDC Director Robert Redfield were ordered to produce related documents by Dec. 30, the head of the coronavirus subcommittee, Rep. Jim Clyburn, D-N.C., said in a statement.
Clyburn said documents obtained as part of the panel s investigation so far showed administration appointees had tried to block or alter more than one dozen scientific reports related to the novel coronavirus as the outbreak continued to grow nationwide.